Bolt Biotherapeutics (BOLT) EBITDA Margin (2020 - 2026)
Bolt Biotherapeutics (BOLT) reported EBITDA Margin of -164060.00% for Q2 2026, down 163568.70 percentage points from -491.30% a year earlier and down 135606.15 percentage points from the prior quarter.
Bolt Biotherapeutics (BOLT) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bolt Biotherapeutics' EBITDA Margin came in at -634.98%, up 638.65 percentage points year-over-year; for FY2025, it was -452.53%, up 474.22 percentage points from FY2024.
- EBITDA Margin has increased for five consecutive years, with a five-year change of +20573.88 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -926.75% in FY2024 (+17.16 pp), -943.91% in FY2023 (+603.57 pp), -1547.48% in FY2022 (+5721.97 pp) and -7269.44% in FY2021 (+13756.96 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBITDA Margin in data going back to Q1 2020.
- Year over year, EBITDA Margin gained in two of the last six quarters, with an average year-over-year change of -31683.79 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2022 (a gain of 3800.26 percentage points); the low point was Q2 2026 (a drop of 163568.70 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -28453.85% (Q1 2026), -273.20% (Q4 2025) and -341.77% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Bolt Biotherapeutics | 6.88 Mn | 6.88 Mn | - | -164,060.00% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -164,060.00% |
| Mar 31, 2026 | -28,453.85% |
| Dec 31, 2025 | -273.20% |
| Sep 30, 2025 | -341.77% |
| Jun 30, 2025 | -491.30% |
| Mar 31, 2025 | -958.76% |
| Sep 30, 2024 | -1,402.54% |
| Jun 30, 2024 | -1,736.47% |
| Mar 31, 2024 | -315.40% |
| Dec 31, 2023 | -923.84% |
| Sep 30, 2023 | -700.99% |
| Jun 30, 2023 | -1,351.99% |
| Mar 31, 2023 | -982.91% |
| Dec 31, 2022 | -1,458.40% |
| Sep 30, 2022 | -1,037.26% |
| Jun 30, 2022 | -1,626.06% |
| Mar 31, 2022 | -2,892.87% |
| Dec 31, 2021 | -5,258.66% |
| Sep 30, 2021 | -3,088.03% |
| Jun 30, 2020 | -16,417.91% |
Bolt Biotherapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();